Navigation Links
Wake Forest Baptist Names Julie Ann Freischlag, M.D., Chief Executive Officer
Date:2/14/2017

WINSTON-SALEM, N.C., Feb. 14, 2017 /PRNewswire-USNewswire/ -- Wake Forest Baptist Medical Center today announced Julie Ann Freischlag, (pronounced FRY-shlog), M.D., as its new chief executive officer (CEO). Freischlag joins the medical center on May 1 and succeeds CEO John D. McConnell, M.D., who last year announced that he would transition to a new position at the Medical Center, after leading it since 2008.  

As CEO, Freischlag will oversee the full scope of Wake Forest Baptist's academic health system, which includes Wake Forest School of Medicine, Wake Forest Baptist Health, Wake Forest Innovations, Wake Forest Innovation Quarter, and a network of hospitals, physician practices and medical/surgical services. The CEO reports to the medical center's board of directors.

Continue Reading
Julie Ann Freischlag, M.D., joins Wake Forest Baptist Medical Center as chief executive officer on May 1, 2017.
Julie Ann Freischlag, M.D., joins Wake Forest Baptist Medical Center as chief executive officer on May 1, 2017.

Freischlag, 62, comes to Winston-Salem from Sacramento, California where she is currently Vice Chancellor for Human Health Sciences and Dean of the School of Medicine at the University of California Davis (UC Davis). In this role, Freischlag directs UC Davis' academic, research and clinical programs, which include a 627-bed acute care hospital, a 1,000 physician private practice group, a school of nursing and a staff of 10,000 employees. 

Nathan Hatch, Ph.D., president of Wake Forest University, who co-chaired the CEO search with Wake Forest Baptist board member Art Gibel, said Freischlag possesses the full range of academic medical experience and clinical expertise to take Wake Forest Baptist to the next level. "Julie has devoted her career to improving the health of her patients, which coincides with our mission. In addition to her superb professional abilities, Julie is well known and widely respected within the field as a collaborator, a mentor and a strong community leader. We are very fortunate that she has chosen to join us."

Steve Robertson, chairman of Wake Forest Baptist's board of directors, added his praise for the many accomplishments led by McConnell during his tenure as CEO. "We are also very grateful to John for his vision and leadership of Wake Forest Baptist over these past eight plus years.  As the first ever CEO of the integrated medical center, John has been a trail blazer and made it ready for this smooth transition to Julie as our next CEO."

As a vascular surgeon with 30 years of experience at top academic medical centers, Freischlag is nationally recognized as a leader in the advancement of medical education and training, the expansion of research opportunities and the improvement in patient and family-centered care.

Freischlag is also a member of the National Academy of Medicine, considered the highest recognition of professional achievement and commitment to volunteer service in medicine, as determined by her peers through election.

Prior to her career at UC Davis, Freischlag served as the first female chair of the department of surgery and surgeon-in-chief at Johns Hopkins Medical Institutions and earlier as professor and chief of vascular surgery at University of California Los Angeles (UCLA). 

She received an undergraduate degree in biology from the University of Illinois, her medical degree from Rush University Medical College in Chicago and completed a surgical residency and vascular fellowship at UCLA.

Freischlag has served in multiple national leadership roles, including immediate past president of the Society for Vascular Surgery Foundation, past chair of the Board of Regents of the American College of Surgeons, past president of the Society for Vascular Surgery and past president of the Association of VA Surgeons and the Society of Surgical Chairs.

Freischlag and her husband Phil Roethle (pronounced RAYT-lee), a retired financial executive, will relocate soon to the Winston-Salem area. Their family includes Matthew and wife Michelle, Paul and wife Gretchen, Taylor, a senior at the University of Maryland, and two grandchildren, Zoe and Milo.

Wake Forest Baptist Medical Center (www.wakehealth.edu) is a nationally prominent academic medical center in Winston-Salem, North Carolina, with an integrated enterprise incorporating hospitals, clinics, diagnostic centers and other primary and specialty care facilities that serve the residents of 24 counties in northwest North Carolina and southwest Virginia. The Medical Center's divisions are Wake Forest Baptist Health, a regional clinical system that includes Brenner Children's Hospital and more than 150 locations, 900 physicians and 1,000 acute care beds; Wake Forest School of Medicine, a recognized leader in cutting-edge research and experiential medical education; and Wake Forest Innovations, which commercializes the discoveries and research capabilities of the Medical Center and operates Wake Forest Innovation Quarter, an urban district devoted to driving regional economic growth and building vibrant community. Wake Forest Baptist clinical, research and educational programs are annually ranked among the best in the country by U.S. News & World Report.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/wake-forest-baptist-names-julie-ann-freischlag-md-chief-executive-officer-300407118.html


'/>"/>
SOURCE Wake Forest Baptist Medical Center
Copyright©2017 PR Newswire.
All rights reserved


Related biology news :

1. Study led by NUS scientists reveals escalating cost of forest conservation
2. In the Northeast, forests with entirely native flora are not the norm
3. Loss of eastern hemlock will affect forest water use
4. Wexford Science & Technology Makes $150 Million Investment in Wake Forest Innovation Quarter
5. Energy supply from hydropower projects depends on rainforest conservation
6. Maps developed to help forest industry outwit climate change
7. Amazon River exhales virtually all carbon taken up by rain forest
8. Reforestation study shows trade-offs between water, carbon and timber
9. Study explores 100 year increase in forestry diseases
10. Forest and soil carbon is important but does not offset fossil fuel emissions
11. Threatened frogs palmed off as forests disappear
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... Report Highlights The global biosurgery market should ... 2016 at a compound annual growth rate (CAGR) of ... An overview of the global market for biosurgery. - ... and 2016, and projections of compound annual growth rates ... the basis of product type, source, application, and region. ...
(Date:2/7/2017)... WARSAW, Ind. , Feb. 7, 2017 ... global leader in musculoskeletal healthcare, will present at the ... Lotte New York Palace Hotel on Wednesday, February 15, ... A live webcast of the presentation can be accessed ... for replay following the conference via Zimmer Biomet,s Investor ...
(Date:2/6/2017)... 2017 According to Acuity Market Intelligence, ... authorities to continue to embrace biometric and digital ... Automated Border Control (ABC) eGates and 1436 Automated ... than 163 ports of entry across the globe. ... a combined CAGR of 37%. APC Kiosks reached ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... ... 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused on drug delivery, ... Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ( DLP-119 ... to deliver therapeutic levels of olanzapine for a period of 3 months., “We are ...
(Date:2/24/2017)... , Feb. 24, 2017 Provectus ... or the "Company"), a clinical-stage oncology and dermatology ... the deadline to participate in its previously announced ... consisting of shares of common stock and Series ... holders of listed warrants. As ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
(Date:2/24/2017)... Blood Corporation (NYSE: CO ) ("CCBC" or ... laboratory testing, hematopoietic stem cell processing and stem cell ... the third quarter and first nine months of fiscal ... Quarter of Fiscal 2017 Highlights Revenues ... 18.6% to RMB200.9 million ($28.9 million). ...
Breaking Biology Technology: